Aug 27, 2024, 17:43
2nd trial for NET going into the world of CAR T-Cell
Lama Amer, Fellow at the University of Toronto, shared on X:
“2nd trial for NET going into the world of CAR T-Cell . Excited to see what the future holds
Phase I CAR T-cell clinical trial targeting the molecule IL13Rα2 found on surface of some tumors is being conducted at UCLA.
This trial investigates the safety and effectiveness of IL13Rα2 CAR T-cells in treating advanced melanoma and other solid tumors, such as neuroendocrine cancer, aiming to improve treatment options for advanced cancers.”
Source: Lama Amer/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12